GRCE vs MNDY · $35.0M cap vs P/E 32, rev $1.23B
Grace Therapeutics, Inc. (GRCE) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
GRCE does not have a complete income-statement cache yet.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
GRCE currently screens at market cap $35.0M. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the GRCE and MNDY stock pages for the full models.
Not investment advice.